Global PCR and Real-time PCR Molecular Diagnostics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 103

Published Date: 14 Jan 2022

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The PCR and Real-time PCR Molecular Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global PCR and Real-time PCR Molecular Diagnostics market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Infectious Diseases Testing accounting for  % of the PCR and Real-time PCR Molecular Diagnostics global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Instruments segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of PCR and Real-time PCR Molecular Diagnostics include Abbott Laboratories, bioMereieux SA, Danaher Corporation, Bio-Rad Laboratories, and QIAGEN N.V, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
PCR and Real-time PCR Molecular Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Instruments
    Reagents
    Consumables

Market segment by Application, can be divided into
    Infectious Diseases Testing
    Oncology Testing
    Genetic Testing
    Others

Market segment by players, this report covers
    Abbott Laboratories
    bioMereieux SA
    Danaher Corporation
    Bio-Rad Laboratories
    QIAGEN N.V
    F-Hoffmann-La Roche Ltd.
    Genomic Health
    GRIFOLS S.A
    Thermo Fisher Scientific Inc.
    Seegene Inc.
    Hologic Inc.

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe PCR and Real-time PCR Molecular Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of PCR and Real-time PCR Molecular Diagnostics, with revenue, gross margin and global market share of PCR and Real-time PCR Molecular Diagnostics from 2019 to 2022.
Chapter 3, the PCR and Real-time PCR Molecular Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and PCR and Real-time PCR Molecular Diagnostics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe PCR and Real-time PCR Molecular Diagnostics research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of PCR and Real-time PCR Molecular Diagnostics
    1.2 Classification of PCR and Real-time PCR Molecular Diagnostics by Type
        1.2.1 Overview: Global PCR and Real-time PCR Molecular Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Type in 2021
        1.2.3 Instruments
        1.2.4 Reagents
        1.2.5 Consumables
    1.3 Global PCR and Real-time PCR Molecular Diagnostics Market by Application
        1.3.1 Overview: Global PCR and Real-time PCR Molecular Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Infectious Diseases Testing
        1.3.3 Oncology Testing
        1.3.4 Genetic Testing
        1.3.5 Others
    1.4 Global PCR and Real-time PCR Molecular Diagnostics Market Size & Forecast
    1.5 Global PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast by Region
        1.5.1 Global PCR and Real-time PCR Molecular Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global PCR and Real-time PCR Molecular Diagnostics Market Size by Region, (2017-2022)
        1.5.3 North America PCR and Real-time PCR Molecular Diagnostics Market Size and Prospect (2017-2028)
        1.5.4 Europe PCR and Real-time PCR Molecular Diagnostics Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Market Size and Prospect (2017-2028)
        1.5.6 South America PCR and Real-time PCR Molecular Diagnostics Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa PCR and Real-time PCR Molecular Diagnostics Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 PCR and Real-time PCR Molecular Diagnostics Market Drivers
        1.6.2 PCR and Real-time PCR Molecular Diagnostics Market Restraints
        1.6.3 PCR and Real-time PCR Molecular Diagnostics Trends Analysis

2 Company Profiles
    2.1 Abbott Laboratories
        2.1.1 Abbott Laboratories Details
        2.1.2 Abbott Laboratories Major Business
        2.1.3 Abbott Laboratories PCR and Real-time PCR Molecular Diagnostics Product and Solutions
        2.1.4 Abbott Laboratories PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Abbott Laboratories Recent Developments and Future Plans
    2.2 bioMereieux SA
        2.2.1 bioMereieux SA Details
        2.2.2 bioMereieux SA Major Business
        2.2.3 bioMereieux SA PCR and Real-time PCR Molecular Diagnostics Product and Solutions
        2.2.4 bioMereieux SA PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 bioMereieux SA Recent Developments and Future Plans
    2.3 Danaher Corporation
        2.3.1 Danaher Corporation Details
        2.3.2 Danaher Corporation Major Business
        2.3.3 Danaher Corporation PCR and Real-time PCR Molecular Diagnostics Product and Solutions
        2.3.4 Danaher Corporation PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Danaher Corporation Recent Developments and Future Plans
    2.4 Bio-Rad Laboratories
        2.4.1 Bio-Rad Laboratories Details
        2.4.2 Bio-Rad Laboratories Major Business
        2.4.3 Bio-Rad Laboratories PCR and Real-time PCR Molecular Diagnostics Product and Solutions
        2.4.4 Bio-Rad Laboratories PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Bio-Rad Laboratories Recent Developments and Future Plans
    2.5 QIAGEN N.V
        2.5.1 QIAGEN N.V Details
        2.5.2 QIAGEN N.V Major Business
        2.5.3 QIAGEN N.V PCR and Real-time PCR Molecular Diagnostics Product and Solutions
        2.5.4 QIAGEN N.V PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 QIAGEN N.V Recent Developments and Future Plans
    2.6 F-Hoffmann-La Roche Ltd.
        2.6.1 F-Hoffmann-La Roche Ltd. Details
        2.6.2 F-Hoffmann-La Roche Ltd. Major Business
        2.6.3 F-Hoffmann-La Roche Ltd. PCR and Real-time PCR Molecular Diagnostics Product and Solutions
        2.6.4 F-Hoffmann-La Roche Ltd. PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 F-Hoffmann-La Roche Ltd. Recent Developments and Future Plans
    2.7 Genomic Health
        2.7.1 Genomic Health Details
        2.7.2 Genomic Health Major Business
        2.7.3 Genomic Health PCR and Real-time PCR Molecular Diagnostics Product and Solutions
        2.7.4 Genomic Health PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Genomic Health Recent Developments and Future Plans
    2.8 GRIFOLS S.A
        2.8.1 GRIFOLS S.A Details
        2.8.2 GRIFOLS S.A Major Business
        2.8.3 GRIFOLS S.A PCR and Real-time PCR Molecular Diagnostics Product and Solutions
        2.8.4 GRIFOLS S.A PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 GRIFOLS S.A Recent Developments and Future Plans
    2.9 Thermo Fisher Scientific Inc.
        2.9.1 Thermo Fisher Scientific Inc. Details
        2.9.2 Thermo Fisher Scientific Inc. Major Business
        2.9.3 Thermo Fisher Scientific Inc. PCR and Real-time PCR Molecular Diagnostics Product and Solutions
        2.9.4 Thermo Fisher Scientific Inc. PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
    2.10 Seegene Inc.
        2.10.1 Seegene Inc. Details
        2.10.2 Seegene Inc. Major Business
        2.10.3 Seegene Inc. PCR and Real-time PCR Molecular Diagnostics Product and Solutions
        2.10.4 Seegene Inc. PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Seegene Inc. Recent Developments and Future Plans
    2.11 Hologic Inc.
        2.11.1 Hologic Inc. Details
        2.11.2 Hologic Inc. Major Business
        2.11.3 Hologic Inc. PCR and Real-time PCR Molecular Diagnostics Product and Solutions
        2.11.4 Hologic Inc. PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Hologic Inc. Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global PCR and Real-time PCR Molecular Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 PCR and Real-time PCR Molecular Diagnostics Players Market Share in 2021
        3.2.2 Top 10 PCR and Real-time PCR Molecular Diagnostics Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 PCR and Real-time PCR Molecular Diagnostics Players Head Office, Products and Services Provided
    3.4 PCR and Real-time PCR Molecular Diagnostics Mergers & Acquisitions
    3.5 PCR and Real-time PCR Molecular Diagnostics New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global PCR and Real-time PCR Molecular Diagnostics Revenue and Market Share by Type (2017-2022)
    4.2 Global PCR and Real-time PCR Molecular Diagnostics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Application (2017-2022)
    5.2 Global PCR and Real-time PCR Molecular Diagnostics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America PCR and Real-time PCR Molecular Diagnostics Revenue by Type (2017-2028)
    6.2 North America PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2017-2028)
    6.3 North America PCR and Real-time PCR Molecular Diagnostics Market Size by Country
        6.3.1 North America PCR and Real-time PCR Molecular Diagnostics Revenue by Country (2017-2028)
        6.3.2 United States PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)
        6.3.3 Canada PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)
        6.3.4 Mexico PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe PCR and Real-time PCR Molecular Diagnostics Revenue by Type (2017-2028)
    7.2 Europe PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2017-2028)
    7.3 Europe PCR and Real-time PCR Molecular Diagnostics Market Size by Country
        7.3.1 Europe PCR and Real-time PCR Molecular Diagnostics Revenue by Country (2017-2028)
        7.3.2 Germany PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)
        7.3.3 France PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)
        7.3.5 Russia PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)
        7.3.6 Italy PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Revenue by Type (2017-2028)
    8.2 Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2017-2028)
    8.3 Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Market Size by Region
        8.3.1 Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Revenue by Region (2017-2028)
        8.3.2 China PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)
        8.3.3 Japan PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)
        8.3.4 South Korea PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)
        8.3.5 India PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)
        8.3.7 Australia PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America PCR and Real-time PCR Molecular Diagnostics Revenue by Type (2017-2028)
    9.2 South America PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2017-2028)
    9.3 South America PCR and Real-time PCR Molecular Diagnostics Market Size by Country
        9.3.1 South America PCR and Real-time PCR Molecular Diagnostics Revenue by Country (2017-2028)
        9.3.2 Brazil PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)
        9.3.3 Argentina PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Revenue by Type (2017-2028)
    10.2 Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2017-2028)
    10.3 Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size by Country
        10.3.1 Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Revenue by Country (2017-2028)
        10.3.2 Turkey PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)
        10.3.4 UAE PCR and Real-time PCR Molecular Diagnostics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global PCR and Real-time PCR Molecular Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global PCR and Real-time PCR Molecular Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market PCR and Real-time PCR Molecular Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million) by Region (2017-2022)
    Table 5. Global PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Region (2023-2028)
    Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
    Table 7. Abbott Laboratories Major Business
    Table 8. Abbott Laboratories PCR and Real-time PCR Molecular Diagnostics Product and Solutions
    Table 9. Abbott Laboratories PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. bioMereieux SA Corporate Information, Head Office, and Major Competitors
    Table 11. bioMereieux SA Major Business
    Table 12. bioMereieux SA PCR and Real-time PCR Molecular Diagnostics Product and Solutions
    Table 13. bioMereieux SA PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Danaher Corporation Corporate Information, Head Office, and Major Competitors
    Table 15. Danaher Corporation Major Business
    Table 16. Danaher Corporation PCR and Real-time PCR Molecular Diagnostics Product and Solutions
    Table 17. Danaher Corporation PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
    Table 19. Bio-Rad Laboratories Major Business
    Table 20. Bio-Rad Laboratories PCR and Real-time PCR Molecular Diagnostics Product and Solutions
    Table 21. Bio-Rad Laboratories PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. QIAGEN N.V Corporate Information, Head Office, and Major Competitors
    Table 23. QIAGEN N.V Major Business
    Table 24. QIAGEN N.V PCR and Real-time PCR Molecular Diagnostics Product and Solutions
    Table 25. QIAGEN N.V PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. F-Hoffmann-La Roche Ltd. Corporate Information, Head Office, and Major Competitors
    Table 27. F-Hoffmann-La Roche Ltd. Major Business
    Table 28. F-Hoffmann-La Roche Ltd. PCR and Real-time PCR Molecular Diagnostics Product and Solutions
    Table 29. F-Hoffmann-La Roche Ltd. PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. Genomic Health Corporate Information, Head Office, and Major Competitors
    Table 31. Genomic Health Major Business
    Table 32. Genomic Health PCR and Real-time PCR Molecular Diagnostics Product and Solutions
    Table 33. Genomic Health PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. GRIFOLS S.A Corporate Information, Head Office, and Major Competitors
    Table 35. GRIFOLS S.A Major Business
    Table 36. GRIFOLS S.A PCR and Real-time PCR Molecular Diagnostics Product and Solutions
    Table 37. GRIFOLS S.A PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. Thermo Fisher Scientific Inc. Corporate Information, Head Office, and Major Competitors
    Table 39. Thermo Fisher Scientific Inc. Major Business
    Table 40. Thermo Fisher Scientific Inc. PCR and Real-time PCR Molecular Diagnostics Product and Solutions
    Table 41. Thermo Fisher Scientific Inc. PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Seegene Inc. Corporate Information, Head Office, and Major Competitors
    Table 43. Seegene Inc. Major Business
    Table 44. Seegene Inc. PCR and Real-time PCR Molecular Diagnostics Product and Solutions
    Table 45. Seegene Inc. PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 46. Hologic Inc. Corporate Information, Head Office, and Major Competitors
    Table 47. Hologic Inc. Major Business
    Table 48. Hologic Inc. PCR and Real-time PCR Molecular Diagnostics Product and Solutions
    Table 49. Hologic Inc. PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 50. Global PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 51. Global PCR and Real-time PCR Molecular Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 52. Breakdown of PCR and Real-time PCR Molecular Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 53. PCR and Real-time PCR Molecular Diagnostics Players Head Office, Products and Services Provided
    Table 54. PCR and Real-time PCR Molecular Diagnostics Mergers & Acquisitions in the Past Five Years
    Table 55. PCR and Real-time PCR Molecular Diagnostics New Entrants and Expansion Plans
    Table 56. Global PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million) by Type (2017-2022)
    Table 57. Global PCR and Real-time PCR Molecular Diagnostics Revenue Share by Type (2017-2022)
    Table 58. Global PCR and Real-time PCR Molecular Diagnostics Revenue Forecast by Type (2023-2028)
    Table 59. Global PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2017-2022)
    Table 60. Global PCR and Real-time PCR Molecular Diagnostics Revenue Forecast by Application (2023-2028)
    Table 61. North America PCR and Real-time PCR Molecular Diagnostics Revenue by Type (2017-2022) & (USD Million)
    Table 62. North America PCR and Real-time PCR Molecular Diagnostics Revenue by Type (2023-2028) & (USD Million)
    Table 63. North America PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2017-2022) & (USD Million)
    Table 64. North America PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2023-2028) & (USD Million)
    Table 65. North America PCR and Real-time PCR Molecular Diagnostics Revenue by Country (2017-2022) & (USD Million)
    Table 66. North America PCR and Real-time PCR Molecular Diagnostics Revenue by Country (2023-2028) & (USD Million)
    Table 67. Europe PCR and Real-time PCR Molecular Diagnostics Revenue by Type (2017-2022) & (USD Million)
    Table 68. Europe PCR and Real-time PCR Molecular Diagnostics Revenue by Type (2023-2028) & (USD Million)
    Table 69. Europe PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2017-2022) & (USD Million)
    Table 70. Europe PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2023-2028) & (USD Million)
    Table 71. Europe PCR and Real-time PCR Molecular Diagnostics Revenue by Country (2017-2022) & (USD Million)
    Table 72. Europe PCR and Real-time PCR Molecular Diagnostics Revenue by Country (2023-2028) & (USD Million)
    Table 73. Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Revenue by Type (2017-2022) & (USD Million)
    Table 74. Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Revenue by Type (2023-2028) & (USD Million)
    Table 75. Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2017-2022) & (USD Million)
    Table 76. Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2023-2028) & (USD Million)
    Table 77. Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Revenue by Region (2017-2022) & (USD Million)
    Table 78. Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Revenue by Region (2023-2028) & (USD Million)
    Table 79. South America PCR and Real-time PCR Molecular Diagnostics Revenue by Type (2017-2022) & (USD Million)
    Table 80. South America PCR and Real-time PCR Molecular Diagnostics Revenue by Type (2023-2028) & (USD Million)
    Table 81. South America PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2017-2022) & (USD Million)
    Table 82. South America PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2023-2028) & (USD Million)
    Table 83. South America PCR and Real-time PCR Molecular Diagnostics Revenue by Country (2017-2022) & (USD Million)
    Table 84. South America PCR and Real-time PCR Molecular Diagnostics Revenue by Country (2023-2028) & (USD Million)
    Table 85. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Revenue by Type (2017-2022) & (USD Million)
    Table 86. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Revenue by Type (2023-2028) & (USD Million)
    Table 87. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2017-2022) & (USD Million)
    Table 88. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Revenue by Application (2023-2028) & (USD Million)
    Table 89. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Revenue by Country (2017-2022) & (USD Million)
    Table 90. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. PCR and Real-time PCR Molecular Diagnostics Picture
    Figure 2. Global PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Type in 2021
    Figure 3. Instruments
    Figure 4. Reagents
    Figure 5. Consumables
    Figure 6. PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Application in 2021
    Figure 7. Infectious Diseases Testing Picture
    Figure 8. Oncology Testing Picture
    Figure 9. Genetic Testing Picture
    Figure 10. Others Picture
    Figure 11. Global PCR and Real-time PCR Molecular Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 12. Global PCR and Real-time PCR Molecular Diagnostics Revenue and Forecast (2017-2028) & (USD Million)
    Figure 13. Global PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Region (2017-2028)
    Figure 14. Global PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Region in 2021
    Figure 15. North America PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 16. Europe PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. South America PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 19. Middle East and Africa PCR and Real-time PCR Molecular Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 20. PCR and Real-time PCR Molecular Diagnostics Market Drivers
    Figure 21. PCR and Real-time PCR Molecular Diagnostics Market Restraints
    Figure 22. PCR and Real-time PCR Molecular Diagnostics Market Trends
    Figure 23. Abbott Laboratories Recent Developments and Future Plans
    Figure 24. bioMereieux SA Recent Developments and Future Plans
    Figure 25. Danaher Corporation Recent Developments and Future Plans
    Figure 26. Bio-Rad Laboratories Recent Developments and Future Plans
    Figure 27. QIAGEN N.V Recent Developments and Future Plans
    Figure 28. F-Hoffmann-La Roche Ltd. Recent Developments and Future Plans
    Figure 29. Genomic Health Recent Developments and Future Plans
    Figure 30. GRIFOLS S.A Recent Developments and Future Plans
    Figure 31. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
    Figure 32. Seegene Inc. Recent Developments and Future Plans
    Figure 33. Hologic Inc. Recent Developments and Future Plans
    Figure 34. Global PCR and Real-time PCR Molecular Diagnostics Revenue Share by Players in 2021
    Figure 35. PCR and Real-time PCR Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 36. Global Top 3 Players PCR and Real-time PCR Molecular Diagnostics Revenue Market Share in 2021
    Figure 37. Global Top 10 Players PCR and Real-time PCR Molecular Diagnostics Revenue Market Share in 2021
    Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 39. Global PCR and Real-time PCR Molecular Diagnostics Revenue Share by Type in 2021
    Figure 40. Global PCR and Real-time PCR Molecular Diagnostics Market Share Forecast by Type (2023-2028)
    Figure 41. Global PCR and Real-time PCR Molecular Diagnostics Revenue Share by Application in 2021
    Figure 42. Global PCR and Real-time PCR Molecular Diagnostics Market Share Forecast by Application (2023-2028)
    Figure 43. North America PCR and Real-time PCR Molecular Diagnostics Sales Market Share by Type (2017-2028)
    Figure 44. North America PCR and Real-time PCR Molecular Diagnostics Sales Market Share by Application (2017-2028)
    Figure 45. North America PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Country (2017-2028)
    Figure 46. United States PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 47. Canada PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. Mexico PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. Europe PCR and Real-time PCR Molecular Diagnostics Sales Market Share by Type (2017-2028)
    Figure 50. Europe PCR and Real-time PCR Molecular Diagnostics Sales Market Share by Application (2017-2028)
    Figure 51. Europe PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Country (2017-2028)
    Figure 52. Germany PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. France PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. United Kingdom PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 55. Russia PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. Italy PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Sales Market Share by Type (2017-2028)
    Figure 58. Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Sales Market Share by Application (2017-2028)
    Figure 59. Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Region (2017-2028)
    Figure 60. China PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Japan PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. South Korea PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. India PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. Southeast Asia PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. Australia PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. South America PCR and Real-time PCR Molecular Diagnostics Sales Market Share by Type (2017-2028)
    Figure 67. South America PCR and Real-time PCR Molecular Diagnostics Sales Market Share by Application (2017-2028)
    Figure 68. South America PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Country (2017-2028)
    Figure 69. Brazil PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. Argentina PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 71. Middle East and Africa PCR and Real-time PCR Molecular Diagnostics Sales Market Share by Type (2017-2028)
    Figure 72. Middle East and Africa PCR and Real-time PCR Molecular Diagnostics Sales Market Share by Application (2017-2028)
    Figure 73. Middle East and Africa PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Country (2017-2028)
    Figure 74. Turkey PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Saudi Arabia PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. UAE PCR and Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Methodology
    Figure 78. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Abbott Laboratories
bioMereieux SA
Danaher Corporation
Bio-Rad Laboratories
QIAGEN N.V
F-Hoffmann-La Roche Ltd.
Genomic Health
GRIFOLS S.A
Thermo Fisher Scientific Inc.
Seegene Inc.
Hologic Inc.

Related Reports

Global PCR and Real-time PCR Molecular Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global PCR and Real-time PCR Molecular Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 28 Jan 2021

date Medical Devices & Consumables

The PCR and Real-time PCR Molecular Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Product Tags

pcr real time pcr molecular diagnostics

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>